Viewing Study NCT00193102


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-02-23 @ 12:19 PM
Study NCT ID: NCT00193102
Status: TERMINATED
Last Update Posted: 2011-05-03
First Post: 2005-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer
Sponsor: SCRI Development Innovations, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module